Work

Phase I study of procaspase activating compound -1 (PAC-1) in combination with temozolomide (TMZ) for the treatment of recurrent malignant glioma.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps3164

Authors: Martin Kelly Nicholas, Matthias Holdhoff, Richard A. Peterson, Oana Cristina Danciu, Theodore M. Tarasow, Paul J. Hergenrother, Arkadiusz Z. Dudek

Institutions: University of Illinois Chicago, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, HealthPartners, Vanquish Oncology (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947743059

Cites:

Cited by:

Related to: 10